Sasco Capital Has Raised Sealed Air (SEE) Holding; Sentinel Asset Management Lowered Its Cvs Health Corp. (CVS) Holding

June 19, 2017 - By Maria Brooks

Sentinel Asset Management Inc decreased Cvs Health Corp. (CVS) stake by 16.76% reported in 2016Q4 SEC filing. Sentinel Asset Management Inc sold 62,000 shares as Cvs Health Corp. (CVS)’s stock declined 4.23%. The Sentinel Asset Management Inc holds 308,000 shares with $24.30M value, down from 370,000 last quarter. Cvs Health Corp. now has $76.29B valuation. The stock rose 1.00% or $0.77 reaching $77.83. About 2.98M shares traded. CVS Health Corp (NYSE:CVS) has declined 24.40% since June 19, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

Sasco Capital Inc increased Sealed Air Corp (SEE) stake by 52.69% reported in 2016Q4 SEC filing. Sasco Capital Inc acquired 868,140 shares as Sealed Air Corp (SEE)’s stock declined 9.02%. The Sasco Capital Inc holds 2.52M shares with $114.07M value, up from 1.65M last quarter. Sealed Air Corp now has $8.88B valuation. The stock rose 0.29% or $0.13 reaching $45.16 per share. About 549,712 shares traded. Sealed Air Corp (NYSE:SEE) has declined 6.94% since June 19, 2016 and is downtrending. It has underperformed by 23.64% the S&P500.

Analysts await CVS Health Corp (NYSE:CVS) to report earnings on August, 1. They expect $1.31 EPS, down 0.76% or $0.01 from last year’s $1.32 per share. CVS’s profit will be $1.28 billion for 14.85 P/E if the $1.31 EPS becomes a reality. After $1.17 actual EPS reported by CVS Health Corp for the previous quarter, Wall Street now forecasts 11.97% EPS growth.

Among 17 analysts covering CVS Health (NYSE:CVS), 10 have Buy rating, 0 Sell and 7 Hold. Therefore 59% are positive. CVS Health had 27 analyst reports since July 22, 2015 according to SRatingsIntel. As per Monday, August 24, the company rating was upgraded by Vetr. The firm has “Neutral” rating given on Thursday, December 17 by Goldman Sachs. JP Morgan maintained the stock with “Overweight” rating in Monday, November 2 report. Morgan Stanley downgraded the shares of CVS in report on Monday, June 20 to “Equal-Weight” rating. Jefferies maintained the shares of CVS in report on Thursday, May 12 with “Buy” rating. The company was maintained on Monday, May 9 by Citigroup. Argus Research maintained it with “Buy” rating and $118.0 target in Monday, August 10 report. The stock has “Hold” rating by Deutsche Bank on Wednesday, July 22. The stock has “Outperform” rating by RBC Capital Markets on Wednesday, August 5. The firm earned “Outperform” rating on Monday, November 2 by Oppenheimer.

Investors sentiment decreased to 0.74 in 2016 Q4. Its down 0.24, from 0.98 in 2016Q3. It is negative, as 135 investors sold CVS shares while 627 reduced holdings. 127 funds opened positions while 440 raised stakes. 830.51 million shares or 0.72% less from 836.58 million shares in 2016Q3 were reported. First Pacific Advisors Limited Liability reported 161,800 shares. Guardian Capital Advisors Ltd Partnership holds 0.08% or 7,150 shares. Ci Investments Inc, Ontario – Canada-based fund reported 536,321 shares. Blackrock Investment Ltd Company owns 3.57M shares for 0.33% of their portfolio. Dearborn Prns Ltd Limited Liability Company reported 1.38% of its portfolio in CVS Health Corp (NYSE:CVS). Boltwood Mngmt holds 0.46% of its portfolio in CVS Health Corp (NYSE:CVS) for 7,700 shares. Renaissance Investment Grp Limited Liability Com accumulated 35,360 shares. National Pension invested 0.38% in CVS Health Corp (NYSE:CVS). Ccm Investment Advisers Lc reported 2.08% of its portfolio in CVS Health Corp (NYSE:CVS). Pinnacle Financial Incorporated holds 0.63% or 37,118 shares in its portfolio. Creative Planning stated it has 0.04% of its portfolio in CVS Health Corp (NYSE:CVS). Cleararc Capital owns 25,925 shares or 0.37% of their US portfolio. Boston Common Asset Ltd reported 0.8% in CVS Health Corp (NYSE:CVS). Pzena Lc invested 0.24% of its portfolio in CVS Health Corp (NYSE:CVS). Delta Capital Mngmt Limited Liability Company has 1.7% invested in CVS Health Corp (NYSE:CVS) for 30,250 shares.

Since February 1, 2017, it had 0 insider buys, and 7 selling transactions for $40.53 million activity. MERLO LARRY J sold $5.99 million worth of stock or 76,494 shares. $1.13M worth of CVS Health Corp (NYSE:CVS) was sold by Sussman Andrew on Monday, March 13. On Tuesday, March 21 the insider Brennan Troyen A sold $1.88M. Shares for $7.71M were sold by Denton David M on Friday, March 10. Another trade for 6,029 shares valued at $479,908 was sold by Boratto Eva C. Shares for $4.90M were sold by Roberts Jonathan C.

Sentinel Asset Management Inc increased Vestas Wind Systems A/S (VWDRY) stake by 75,000 shares to 170,000 valued at $3.69M in 2016Q4. It also upped Corporate Office Properties Tr (NYSE:OFC) stake by 31,820 shares and now owns 686,876 shares. Planet Fitness Inc. Cl A was raised too.

Among 11 analysts covering Sealed Air Corporation (NYSE:SEE), 7 have Buy rating, 0 Sell and 4 Hold. Therefore 64% are positive. Sealed Air Corporation had 20 analyst reports since August 4, 2015 according to SRatingsIntel. RBC Capital Markets maintained the shares of SEE in report on Wednesday, April 12 with “Buy” rating. UBS initiated it with “Buy” rating and $54 target in Tuesday, August 23 report. Goldman Sachs downgraded it to “Buy” rating and $50 target in Wednesday, April 5 report. SunTrust initiated the stock with “Buy” rating in Wednesday, July 13 report. The stock has “Hold” rating by Jefferies on Wednesday, April 19. The rating was maintained by Jefferies on Thursday, July 14 with “Hold”. The stock of Sealed Air Corp (NYSE:SEE) earned “Overweight” rating by Barclays Capital on Friday, January 8. The firm earned “Sector Perform” rating on Thursday, May 11 by RBC Capital Markets. The stock of Sealed Air Corp (NYSE:SEE) earned “Buy” rating by Citigroup on Friday, July 15. As per Tuesday, September 13, the company rating was initiated by JP Morgan.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: